Listeria monocytogenes infection associated with alemtuzumab – - a case for better preventive strategies

BACKGROUND: The mortality of septicaemia, meningitis and encephalitis caused by Listeria monocytogenes is 20–40%. Twenty-one cases of invasive listeriosis associated with alemtuzumab, including at least 16 in patients with multiple sclerosis, have been published or reported to the World Health Organ...

Descripción completa

Detalles Bibliográficos
Autores principales: Holmøy, Trygve, von der Lippe, Hedda, Leegaard, Truls Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381036/
https://www.ncbi.nlm.nih.gov/pubmed/28376817
http://dx.doi.org/10.1186/s12883-017-0848-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381036/
https://www.ncbi.nlm.nih.gov/pubmed/28376817
http://dx.doi.org/10.1186/s12883-017-0848-8

Ejemplares similares